Intramed Plus Inc
Total Consideration
$120.2M
Purchase-Price Allocation
Goodwill
$66.5M
OPTION CARE HEALTH, INC. — Key Metrics
3 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$1
Book Value Per Share
$8
Free Cash Flow Per Share
$1
Cash Per Share
$1
Revenue Per Share
$35
OCF Per Share
$2
Return on Equity
15.2%
Return on Assets
6.0%
Return on Invested Capital
9.9%
Debt to Equity
0.88
Current Ratio
1.53
Quick Ratio
0.96
Asset Turnover
1.64
Days Sales Outstanding
30.60
Days Payables Outstanding
51.20
Days Inventory On Hand
37.70
Cash Conversion Cycle
17.10
SBC / Revenue
0.7%
Capex / Revenue
0.7%
Working Capital
$436M
Net Current Asset Value
$-864M
Invested Capital
$2.49B
OCF / Net Income
1.25
FCF / Net Income
1.05
Accruals Ratio (Sloan)
-1.5%
Net Debt
$928M
Net Debt / EBITDA
2.29
Interest Coverage
6.19
Cash Coverage
4.74
Capex Coverage
6.26
Tangible Common Equity
$-590M
TCE / Total Assets
-17.1%
Goodwill / Total Assets
46.5%
NOPAT
$248M
Cash ROIC
8.7%
WC / Revenue
7.7%
Capex / D&A
0.61
Reinvestment Rate
26.9%
Total Payout Ratio
149.3%
Asset Growth vs Revenue Growth
-12.0%
Revenue 5Y CAGR
13.3%
EPS 5Y CAGR
—
FCF 5Y CAGR
16.7%
EBITDA 5Y CAGR
17.4%
Book Value 5Y CAGR
5.5%
Stock Price (FY-end)
$32
Market Cap
$5.20B
P/E Ratio
25.07
P/S Ratio
0.92
P/B Ratio
3.92
P/OCF Ratio
20.14
P/FCF Ratio
23.97
Enterprise Value
$6.13B
EV / EBITDA
15.13
EV / Sales
1.09
EV / FCF
28.24
FCF Yield
4.2%
Shareholder Yield
5.2%
Buyback Yield
6.0%
Capex Yield
0.8%
Operating Leverage
0.38
Graham Number
$15
Shares Variation (YoY)
-5.5%
Beta (5Y)
0.86
Cost of Equity
8.8%
Cost of Debt (after tax)
3.4%
WACC
7.8%
ROIC - WACC Spread
2.1%
52W High
$35
52W Low
$23
Trailing Return 1Y
39.4%
Trailing Return 5Y
109.1%
F-Score (Piotroski)
5.00
M-Score (Beneish)
-2.38
Z-Score (Altman)
3.93
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Beat / Miss vs Estimate
Stock Price on Earnings Dates
OPTION CARE HEALTH, INC. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | -29.50% | 4.90% | 5.00% | 4.80% | 3.50% | 4.00% |
| Foreign Rate Differential | — | — | — | — | — | — |
| Other Adjustments | 2.20% | -0.10% | 0.40% | 0.50% | 0.40% | — |
| R&D Tax Credits | — | — | — | — | — | 0.20% |
| SBC (Nondeductible) | -16.30% | 0.00% | 0.40% | 0.70% | 1.20% | 1.70% |
| Nondeductible Expenses | -8.20% | 0.30% | 0.20% | 0.10% | — | — |
| Valuation Allowance Change | -29.90% | -46.20% | 0.00% | -1.50% | -0.80% | — |
| Effective Tax Rate | -54.00% | -20.10% | 26.80% | 25.50% | 25.30% | 26.60% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $2.8M | −$23.4M | $55.2M | $91.7M | $71.8M | $75.3M |
| Income Taxes Paid (Cash) | $2.9M | $5.7M | $13.4M | $75.2M | $64.5M | $67.3M |
OPTION CARE HEALTH, INC. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.
Revitalized LLC
Purchase-Price Allocation
Goodwill
$6.7M
Intangibles
$5.5M